ClinVar Miner

Submissions for variant NM_017780.4(CHD7):c.6108G>A (p.Pro2036=)

gnomAD frequency: 0.00010  dbSNP: rs372755547
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001697848 SCV000526169 likely benign not provided 2021-02-24 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000866828 SCV001007973 likely benign CHARGE syndrome 2024-01-25 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002481313 SCV002803505 likely benign CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia 2021-12-02 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001697848 SCV004155864 likely benign not provided 2022-09-01 criteria provided, single submitter clinical testing CHD7: BP4, BP7
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004701476 SCV005204024 benign not specified 2024-06-24 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003970176 SCV004777870 likely benign CHD7-related disorder 2023-11-30 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.